FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

411113009: Interferon alfa (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2466564014 Interferon alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2472756018 Interferon alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2466564014 Interferon alfa (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2466564014 Interferon alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2472756018 Interferon alfa en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2472756018 Interferon alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Interferon alfa Is a Injectable interferon false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing interferon alfa-2a (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing interferon alfa-2b (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 10million iu powder and solvent for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 5million iu powder and solvent for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 3million iu injection (pdr for recon)+diluent (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 1million iu injection (pdr for recon)+diluent (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 6million iu/mL injection solution 3mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 18million iu/1mL injection solution (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 6million iu/mL injection solution 0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 4.5million iu/0.5mL prefilled syringe (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 12million iu/mL injection solution 0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 9million iu/0.5mL prefilled syringe (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 15million iu/1mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 25million iu/1mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 50million iu/1mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 25million iu/2.5mL injection solution (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 18million iu/0.6mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2b 50micrograms injection (pdr for recon)+solvent (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2b 150micrograms injection (pdr for recon)+solvent (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2b 120micrograms injection (pdr for recon)+solvent (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2a 180micrograms/mL injection 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing peginterferon alfa-2b (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Ribavirin+interferon alpha-2b The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    PEG-intron redipen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    PEG-intron redipen 150micrograms powder+sterile water 0.5mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    PEG-intron redipen 120micrograms powder+sterile water 0.5mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    PEG-intron redipen 50micrograms powder+sterile water 0.5mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    PEG-intron redipen 80micrograms powder+sterile water 0.5mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 10million iu/2mL injection solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 18million iu/0.5mL injection solution prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfacon-130mcg/mL injection solution 0.3mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 5000000unt/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 25000000unt/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 50000000unt/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 10000000unt/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 3000000unt/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 18,000,000iu/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 25 millioniu/vial solution (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 18 millioniu/vial solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 3 million iu/vial solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 5 million iu/vial solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 30000000iu solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 60million/iu solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 150mcg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 300mcg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 120mcg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 600mcg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 100.000mcg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b 50mcg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Peginterferon alfa-2a-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-n3 human leu 5000000unt/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 6miu/vial injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 9miu/vial injection solution 0.9mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 36000000iu/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 3miu/vial injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 18000000iu/3mL injection solution 3mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 3miu/vial injection solution 0.5mL syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2a 6miu/vial injection solution 0.5mL syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-n1 (substance) Is a False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alpha-2a preparation Is a False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)
    Interferon alfa-2b Is a False Interferon alfa Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start